Streamline Health® To Report Third Quarter 2022 Financial Performance and Provide Corporate Update
December 07, 2022 16:30 ET
|
Streamline Health Solutions, Inc.
Atlanta, GA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to...
Denarius Metals Announces Third Quarter and First Nine Months 2022 Results
November 28, 2022 07:00 ET
|
Denarius Metals Corp.
TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Denarius Metals Corp. (“Denarius Metals” or “the Company”) (TSXV: DSLV; OTCQB: DNRSF) announced today that it has filed its unaudited interim condensed...
Viewbix Reports Third Quarter 2022 Financial Results with a 176% Growth in Revenues Totaling $66 Million
November 22, 2022 16:10 ET
|
Viewbix Inc.
Viewbix reached an operating income of $1.4 million Amihay Hadad, Viewbix, CEO: “We entered the field of digital content through apurchase that has proven itself, financially and synergistic and it...
Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
November 21, 2022 18:30 ET
|
Aridis Pharmaceuticals, Inc.
Top-line data from the Phase 3 clinical trial evaluating AR-301 for the treatment of VAP expected in December of this year LOS GATOS, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Aridis...
RYVYL Reports Third Quarter 2022 Financial Results
November 21, 2022 16:15 ET
|
RYVYL Inc.
Third Quarter 2022 Highlighted by Strong Processing Volume Growth, Company Rebranding and Launch of coyni Platform SAN DIEGO, CA, Nov. 21, 2022 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL)...
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
November 15, 2022 16:05 ET
|
BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on November 15, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
QSAM Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 15, 2022 08:00 ET
|
QSAM Biosciences Inc.
Further Progress Demonstrated in Clinical Program Evaluating CycloSam® Radiopharmaceutical Drug Candidate for Treatment of Metastatic Bone Cancer AUSTIN, Texas, Nov. 15, 2022 (GLOBE...
Qualigen Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 15, 2022 07:30 ET
|
Qualigen Therapeutics, Inc.
Q3 2022 FastPack ® sales increased approximately 25% year-over-yearCompany continues to execute on and advance core therapeutic programs CARLSBAD, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Qualigen...
OMNIQ REPORTS RECORD REVENUE OF $27M FOR Q3 2022 UP 32% OVER Q3 2021 AND RECORD 9 MONTH REVENUE OF $77.5M UP 45% OVER SAME PERIOD OF 2021. - Updated
November 14, 2022 17:54 ET
|
OMNIQ Corp.
SALT LAKE CITY, Nov. 14, 2022 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced...
Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern
November 14, 2022 16:41 ET
|
Interpace Biosciences, Inc.
Q3 Revenue of $8.2 million up 2% versus Prior YearQ3 Adjusted EBITDA PositiveCash and Cash Equivalents total $6.3 million as of September 30, 2022 PARSIPPANY, NJ, Nov. 14, 2022 (GLOBE NEWSWIRE)...